Can you provide examples of proteins affected by lipitor?

How Lipitor Works on Proteins

Lipitor (atorvastatin) inhibits HMG-CoA reductase, a key enzyme in the mevalonate pathway that produces cholesterol. This enzyme is the primary protein target, blocking conversion of HMG-CoA to mevalonate and reducing LDL cholesterol synthesis in the liver.[1]

Other Proteins Downstream in the Pathway

Inhibiting HMG-CoA reductase disrupts production of isoprenoids, which prenylate (modify) several proteins:
- Small GTPases (Rho, Ras, Rac): These lose prenylation, impairing their membrane localization and signaling. RhoA inhibition reduces vascular smooth muscle proliferation; Ras and Rac effects limit cell growth and inflammation.[2][3]
- Lamin proteins: Nuclear lamins require farnesylation for stability; disruption contributes to cellular effects in long-term statin use.[4]

Indirect Effects on Liver and Vascular Proteins

Lipitor upregulates LDL receptors (via SREBP-2 pathway), increasing hepatic LDL clearance. It also stabilizes eNOS (endothelial nitric oxide synthase) by reducing RhoA, improving vasodilation.[1][2]

Clinical Evidence from Studies

Trials like ASCOT-LLA show atorvastatin lowers cardiovascular events by 36% through these mechanisms, confirmed in proteomic analyses identifying HMGCR and GTPase modulation.[5]

[1]: FDA Label for Lipitor
[2]: Nature Reviews Drug Discovery - Statin Mechanisms
[3]: Circulation Research - Rho GTPases and Statins
[4]: Journal of Biological Chemistry - Lamin Prenylation
[5]: Lancet - ASCOT-LLA Trial